Financial Analysis of Novartis

4. PHARMACEUTICAL INDUSTRY IN INDIA (Contd..) e.g. PARACETAMOL e.g. Vicks Syrup e.g. GLUCOSE (CROCIN) Paracetamol SALINE Dextromethorphan

9. NOVARTIS INDIA- EXECUTIVE COMMITTEE

10. SHAREHOLDING PATTERN OF NOVARTIS INDIA

11. MARKET SHARE OF MNC PHARMA COMPANIES IN INDIA 1.8% NOVARTIS 5 2.2% AVENTIS 4 2.2% ABBOTT 3 3.0% PFIZER 2 5.6% GLAXO 1 MARKET SHARE COMPANIES RANK

13. SALES OF NOVARTIS INDIA IN 2006-2007.

14. GROWTH COMPARISON FOR NOVARTIS (0.58%) 6.06% 3.71% Total Expenses 6.08% 3.29% 9.74% Total Income 19.06% 16.31% 40.45% Other Income 5.20% 2.28% 7.05% Sales 2004-2005 2005-2006 2006-2007

15. EXPENSES AS % OF SALES FOR NOVARTIS 0.70% 0.19% 0.18% Interest 1.86% 2.46% 2.61% Depreciation 4.68% 2.20% 5.65% Material Cost 45.23% 50.37% 46.20% Purchase of Traded Goods 2004-2005 2005-2006 2006-2007

16. GRAPH SHOWING PAT FOR 4 YEARS

17. WORKING CAPITAL RATIOS CURRENT RATIO v/s QUICK RATIO

18. TURNOVER RATIOS

19. TURNOVER RATIOS (contd…)

20. TURNOVER RATIOS (contd…)

21. GROSS PROFIT MARGIN

22. LEVERAGE RATIO OF NOVARTIS 6.86 32.1 112.6 143.5 INTEREST-COVERAGE RATIO 0.01 0.01 0.01 0.01 L.T. DEBT TO EQUITY 2003-2004 2004-2005 2005-2006 2006-2007 RATIO

23. GRAPH OF NET PROFIT MARGIN

24. GRAPH OF RETURN ON NET WORTH

25. GRAPH OF RETURN ON EQUITY

26. GRAPH OF P/E

27. GRAPH OF EPS

28. DIVIDEND PER SHARE @ F.V. of Rs. 5 300 200 100 Rs. % of FV

29. DIVIDEND PAYOUT RATIO

30. BETA FOR NOVARTIS Beta value for Novartis for the year 2006-2007 is

32. THANK YOU